The term 20S Proteasome α6 inhibitors designates a specific class of compounds or molecules that have been intricately crafted to interact with the α6 subunit within the 20S proteasome complex. The 20S proteasome stands as a pivotal cellular apparatus responsible for the controlled degradation of proteins, wielding profound influence over an array of essential cellular processes including protein homeostasis and regulatory mechanisms. The inhibitors tailored for the α6 subunit encompass a diverse array of chemical structures, each ingeniously engineered to establish distinct and specific interactions with this vital component.
At its core, these inhibitors harbor the primary objective of intricately fine-tuning the activity of the α6 subunit ensconced within the 20S proteasome assembly. Through their engagement with α6, these inhibitors possess the potential to orchestrate cascading effects that reverberate through the larger proteasome machinery, ultimately shaping the degradation of select proteins. The crux of these inhibitors' efficacy lies within their precision-engineered ability to selectively interact with the α6 subunit, targeting its active sites or employing unique molecular mechanisms that may perturb or modulate its native functionality.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
ONX 0912 is a proteasome inhibitor that has been investigated for its effects on multiple proteasome subunits, including α6. | ||||||
Proteasome Inhibitor I | 158442-41-2 | sc-3127 | 1 mg | $86.00 | 1 | |
PSI is a peptide aldehyde proteasome inhibitor that can target α6 among other proteasome subunits. | ||||||